Skip to main content
Log in

Activities of Tetramethylene-Bis-Onium Reversible Cholinesterase Inhibitors as Influenced by the Nature of the Onium Atom

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Inorganic tetramethylene bis-onium compounds were studied as reversible inhibitors of various cholinesterases (ChE), i.e., human erythrocyte acetyl-ChE, horse blood serum butyryl-ChE, grass frog Rana temporaria brain ChE, and Pacific squid Todarodes pacificus and commander squid Berryteuthis magister visual ganglia ChE from various habitats in the northwest Pacific Ocean, in order to study the influence of the nature of the onium atom on their anti-ChE activities. bis-Phosphonium inhibitors turned out to be significantly more potent effectors than bis-ammonium compounds, which may actually have been due to the significant increases of size and hydrophobicity of the onium groups. The bis-ammonium organosilicon compound and its monoammonium analog turned out to be equally active as reversible ChE inhibitors in mammals. The bis-phenyliodonium derivative was studied for the first 7time, was characterized by significantly increased hydrophobicity due to introduction of F atoms into the tetramethylene spacer in the onium chain, and exhibited marked anti-ChE activity with respect to mammalian ChE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. N. Moralev and E. V. Rozengart, Comparative Enzymology of Cholinesterases, International University Lines, La Jolla, Calif. (2007).

    Google Scholar 

  2. J. P. Long, Handb. Exp. Pharmakol., 15, 374 – 427 (1963).

    Article  Google Scholar 

  3. E. V. Rozengart and N. E. Basova, Dokl. Akad. Nauk, 395, 699 – 703 (2004).

    Google Scholar 

  4. E. V. Rozengart and N. E. Basova, Zh. Evol. Biokhim. Fiziol., 46, 3 – 16 (2010).

    CAS  PubMed  Google Scholar 

  5. E. V. Rozengart and N. E. Basova, Zh. Evol. Biokhim. Fiziol., 46, 359 – 369 (2010).

    CAS  PubMed  Google Scholar 

  6. E. V. Rozengart, N. E. Basova, S. N. Moralev, et al., Chem.-Biol. Interact., 203(1), 3 – 9 (2013).

  7. E. V. Rozengart and B. S. Zhorov, Dokl. Akad. Nauk SSSR, 273, 505 – 508 (1983).

    CAS  PubMed  Google Scholar 

  8. E. V. Rozengart, B. S. Zhorov, A. E. Khovanskikh, et al., Zh. Evol. Biokhim. Fiziol., 30, 168 – 186 (1994).

    CAS  PubMed  Google Scholar 

  9. E. V. Rozengart, A. A. Suvorov, A. E. Khovanskikh, et al., Khim.-farm. Zh., 30(8), 20 – 21 (1996); Chem. Pharm. J., 30(8), 510 – 512 (1996).

  10. E. V. Rozengart, N. N. Shestakova, S. O. Prokator, and N. E. Basova, Zh. Evol. Biokhim. Fiziol., 31, 387 – 395 (1995).

    CAS  PubMed  Google Scholar 

  11. A. P. Brestkin, T. N. Vinyar, and E. V. Rozengart, Ukr. Biokhim. Zh., 55, 77 – 79 (1983).

    CAS  PubMed  Google Scholar 

  12. A. P. Brestkin, T. N. Vinyar, E. V. Rozengart, et al., Neurokhimiya, 2, 212 – 216 (1983).

    CAS  Google Scholar 

  13. A. P. Brestkin, V. S. Brovko, E. V. Rozengart, et al., Zh. Evol. Biokhim. Fiziol., 22, 123 – 126 (1986).

    CAS  PubMed  Google Scholar 

  14. A. P. Brestkin, E. V. Rozengart, L. M. Yagupol’skii, et al., Dokl. Akad. Nauk SSSR, 275, 1425 – 1428 (1984).

    CAS  Google Scholar 

  15. A. P. Brestkin, I. L. Brik, and N. E. Teplov, Biokhimiya, 33, 1059 – 1068 (1968).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Rozengart.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 8, pp. 12 – 15, August, 2016.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basova, N.E., Kormilitsyn, B.N., Perchenok, A.Y. et al. Activities of Tetramethylene-Bis-Onium Reversible Cholinesterase Inhibitors as Influenced by the Nature of the Onium Atom. Pharm Chem J 50, 509–512 (2016). https://doi.org/10.1007/s11094-016-1478-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-016-1478-y

Keywords

Navigation